Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Sleep Apnea, Obstructive 1Radiation Injuries 1Lymphoma, Follicular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Radiotherapy 8Cisplatin 3Carboplatin 3sargramostim 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Donepezil 2cevimeline 1beta Carotene 1alpha-Tocopherol 1Zinc Sulfate 1Vortioxetine 1Vitamin E 1Standard of Care 1Sodium Chloride 1Salts 1Radiotherapy, Conformal 1Radiosurgery 1Oxygen 1Oxaliplatin 1Neck Dissection 1Mometasone Furoate 1Meditation 1Hyperbaric Oxygenation 1Glutamine 1G(M1) Ganglioside 1Filgrastim 1Fibroblast Growth Factor 7 1Etoposide 1Erythropoietin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Radiation Injuries × Mometasone Furoate × Clear all
NCT00438659 2016-08-01

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Alliance for Clinical Trials in Oncology

Phase 3 Completed
176 enrolled 10 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Radiation Injuries, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡